The efficacy of teflubenzuron (Calicide ) for the treatment of farmed Atlantic salmon Salmo salar L. infested with sea lice Lepeophtheirus salmonis (Krøyer, 1838), was investigated at low water temperatures in 2 commercial salmon farms. Calicide , coated on commercial feed pellets, was administered orally at 10 mg kg -1 d -1 for 7 consecutive days. Fish were randomly sampled and lice numbers recorded from both treated and control groups on 3 or 4 sampling occasions post-medication. Statistically significant reductions in the number of L. salmonis per fish were recorded. Maximum efficacy was observed toward chalimus and preadult stages of L. salmonis, and was achieved approximately 26 d post-medication. No adverse drug reactions or palatability problems were associated with the treatments.
KEY WORDS: Sea lice · Lepeophtheirus salmonis · Efficacy · Teflubenzuron
Resale or republication not permitted without written consent of the publisherDis Aquat Org 51: [101][102][103][104][105][106] 2002 as Calicide ® in the UK (a medicinal premix containing 100% teflubenzuron) and Ektobann ® in Norway (a medicated feed containing 2 kg teflubenzuron per tonne fish feed), teflubenzuron has been used as a treatment for sea lice infestations in Norway since 1996 and in the UK since 2000 (Branson et al. 2000, Ritchie unpubl. data). Branson et al. (2000) documented that teflubenzuron has been extensively tested as a treatment for L. salmonis and demonstrated that when administered orally at 10 mg kg -1 fish d -1 for 7 consecutive days teflubenzuron was highly effective in trials conducted at water temperatures ranging from 11 to 15°C. Branson et al. (2000), however, did not address the question of efficacy at low water temperatures, and consequently questions as to whether adequate tissue levels would be achieved at low water temperatures, and whether or not chitin production in the sea lice would be sufficient at such temperatures to be affected by the teflubenzuron, were not answered.Teflubenzuron has been shown to achieve therapeutic levels in the skin and muscle of Atlantic salmon at temperatures of 10 and 6°C when given at a dose rate of 10 mg kg -1 body wt d -1 for 7 d (Hoff et al. 1997, Auger et al. 1999.The aim of the present study was to evaluate the clinical efficacy of teflubenzuron towards infestations of Lepeophtheirus salmonis under commercial conditions at low water temperatures.
MATERIALS AND METHODSClinical trials were conducted in 1995 and 1996 at 2 commercial Atlantic salmon sea sites on the west coast of Norway, Hordaland County (Site 1) and More and Romsdal County (Site 2). In compliance with regulatory guidelines, both trials were conducted according to the 'Principles of Good Clinical Practice'. Descriptions of each site and the lice treatment histories are given in Table 1.Trials were designed with a ratio of 1 untreated control cage to 4 or 5 treated cages. The position of the control cages was randomised. Details pertaining to the dates of treatment, sampling dates and water temperatures ...